Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of transthyretin amyloidosis.
Condoluci A, Théaudin M, Schwotzer R, Pazhenkottil AP, Arosio P, Averaimo M, Bacher U, Bode P, Cavalli A, Dirnhofer S, Djerbi N, Dobner S, Fehr T, Garofalo M, Gaspert A, Gerull S, Heimgartner R, Hübers A, Jung HH, Kessler C, Knöpfel R, Laptseva N, Magini G, Manka R, Mazzucchelli L, Meyer M, Mihaylova V, Monney P, Mylonas A, Nkoulou R, Pabst T, Pfister O, Rüfer A, Schmidt A, Seeger H, Stämpfli SF, Stirnimann G, Suter T, Treglia G, Tzankov A, Vetter F, Zweier M, Flammer AJ, Gerber B. Condoluci A, et al. Among authors: schwotzer r. Swiss Med Wkly. 2021 Oct 20;151:w30053. doi: 10.4414/smw.2021.w30053. eCollection 2021 Oct 11. Swiss Med Wkly. 2021. PMID: 34694105 Free article.
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden.
Schwotzer R, Manz MG, Pederiva S, Waibel C, Caspar C, Lerch E, Flammer AJ, Brouwers S, Seeger H, Heimgartner R, Fehr T, Rossi D, Bianchi E, Stüssi G, Ghilardi G, Gerber B. Schwotzer R, et al. Hematol Oncol. 2019 Dec;37(5):595-600. doi: 10.1002/hon.2677. Epub 2019 Nov 6. Hematol Oncol. 2019. PMID: 31486522
Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis.
Schwotzer R, Flammer AJ, Gerull S, Pabst T, Arosio P, Averaimo M, Bacher VU, Bode P, Cavalli A, Concoluci A, Dirnhofer S, Djerbi N, Dobner SW, Fehr T, Garofalo M, Gaspert A, Heimgartner R, Hübers A, Jung HH, Kessler C, Knöpfel R, Laptseva N, Manka R, Mazzucchelli L, Meyer M, Mihaylova V, Monney P, Mylonas A, Nkoulou R, Pazhenkottil A, Pfister O, Rüfer A, Schmidt A, Seeger H, Stämpfli SF, Stirnimann G, Suter T, Théaudin M, Treglia G, Tzankov A, Vetter F, Zweier M, Gerber B. Schwotzer R, et al. Swiss Med Wkly. 2020 Dec 5;150:w20364. doi: 10.4414/smw.2020.20364. eCollection 2020 Nov 30. Swiss Med Wkly. 2020. PMID: 33277911 Free article.
Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis.
Zampiccoli E, Barthelmes J, Kreysing L, Nägele MP, Nebunu D, Haider T, von Eckardstein A, Gerber B, Schwotzer R, Ruschitzka F, Sudano I, Flammer AJ. Zampiccoli E, et al. Among authors: schwotzer r. ESC Heart Fail. 2022 Apr;9(2):1186-1194. doi: 10.1002/ehf2.13792. Epub 2022 Jan 21. ESC Heart Fail. 2022. PMID: 35060356 Free PMC article.
Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry.
Brouwers S, Heimgartner R, Laptseva N, Aguzzi A, Ehl NF, Fehr T, Hitz F, Jung HH, Kälin J, Manz MG, Müllhaupt B, Ruschitzka F, Seeger H, Stussi G, Zweier M, Flammer AJ, Gerber B, Schwotzer R. Brouwers S, et al. Among authors: schwotzer r. Swiss Med Wkly. 2024 Feb 15;154:3485. doi: 10.57187/s.3485. Swiss Med Wkly. 2024. PMID: 38579306 Free article.
19 results